Thumbnail

DEEP VEIN THROMBOSIS MARKET - PIPELINE INTELLIGENCE, 2020

Looking to buy the report?

Introduction

Deep vein thrombosis (DVT) occurs when a blood clot (thrombus) forms in one or more of the deep veins in your body, usually in your legs. DVT can cause leg pain or swelling, but it can also occur without any symptoms. DVT can develop if a person has definite medical conditions that particularly effect blood clots. Another reason for DVT is that if any person doesn’t move for a long time, such as after surgery or an accident, or when confined to bed. DVT may lead to major health problems and, in few cases, it can even be a fatal. Some of the risk factors for DVT are increasing age, personal or family history, smoking, being overweight or obese, and several other factors.

The prevalence of DVT is increasing because of many reasons, one among them being the rising geriatric population across the globe, as aging is one of the risk factors for developing DVT. According to the CDC, it is estimated that the approximately 900,000 people could be affected (1 to 2 per 1,000) each year in the United States alone. Given the increasing number of people associated with DVT, advances are required for patients around the world.

Report Coverage

This report by Mordor Intelligence provides extensive insights into the current scenario and growth prospects of the market studied. Detailed graphical representations of the pipeline landscape, based on various phases, and the status of clinical trials, across major regions of the world, are given, with data obtained from multiple sources. The report also comprises a list of key sponsors with pipeline products for the concerned market.

Deep Vein Thrombosis (DVT) Clinical Trial Analysis by Phase and Status

  • The clinical trial analysis for deep vein thrombosis indicates that there are around XX number of trials under various phases
  • Phase X trials accounted for the majority share
  • The trial data analysis suggests a number of ongoing trials, as well as ones that have been terminated

Deep Vein Thrombosis (DVT) Clinical Trial Analysis by Geography

  • By geography, the scope of the report covers the regional assessment for clinical trials, globally. It covers concise information regarding registered clinical trials in different countries, across several developed and emerging markets
  • The major driving factor for the market is  the rising number of cases across the globe. The overall prevalence of venous thromboembolism (VTE) is increasing and, according to the comprehensive scientific review by the World Thrombosis Day (WTD) steering committee, approximately 10 million cases of VTE occur annually, across low, middle, and high income countries

Key Sponsors in Deep Vein Thrombosis (DVT) Clinical Trials

The report will cover analysis on trails and information on key sponsors, companies, and researchers.

Research Methodology

Our data collection team builds scientific research models, based on data sourced from various internal databases, primary and secondary researches, and our in-house team of research experts. The pipeline assessment reports are generated based on information procured from various stakeholders, such as sponsors, clinical trial organizations, pharmaceutical companies, government bodies, trade agencies, industry journals, scientific literature databases, investor reports, press release statements, and several other sources. The data generated using secondary research and primary research is validated through discussions with industry KOL’s and C-suite executives. The data presented in the reports is continuously updated to incorporate the most relevant and authentic information to our clients.

Reasons to buy the Report

This report will help you to understand

  • The number of clinical trials that are being conducted worldwide
  • The key products under development (Phase I, Phase II, and Phase III)
  • The main areas of research under development (by product, mechanism of action, molecule, delivery, etc.)
  • The average recruitment size in trials
  • Key deals between institutions and industries
  • Insights on regional- and country-level data
  • Dormant and discontinued studies across the category
  • Information on key sponsors and profiles
  • Protocol and design comparisons, to generate the best solution for your product development strategy

 

1. Introduction

2. Research Methodology

3. Disease Epidemiology and Trends

4. Healthcare Expenditure and R&D Trends

5. Executive Summary

6. Clinical Trials Segmentation by Phase

                6.1 Phase-III Product Candidates

                6.2 Phase-II Product Candidates

                6.3 Phase-I Product Candidates

7. Clinical Trials, Segmentation by Status

                7.1 Suspended

                7.2 Terminated

                7.3 Withdrawn

                7.4 Ongoing

                7.5 Completed

                7.6 Others

8. Pipeline Therapeutic Assessment (Infographic Charts and a Brief Description)

                8.1. By Clinical Phase and Molecule Type

                8.2. By Clinical Phase and Route of Administration

                8.3 By Sponsor/Collaborator/Institutions

                8.4 By Geography

9. Market Updates

10. Key Sponsor Profiles

11. Sources and Disclaimer

12. About Mordor Intelligence

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Looking to customize report?

Email

Message

By submitting, you confirm that you agree to our privacy policy